Ledger.Open graph →
SEC Form D · filed September 16, 2020

Tentarix Biotherapeutics, LP

Offering
$50.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LA JOLLA, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Srinivas Akkaraju · SOUTH SAN FRANCISCO, CADirectorJerel Davis · Cleveland, OHDirectorCory Freedland · New York, NYDirectorAlyssa Lochbaum · La Jolla, CAExecSrinivas Akkaraju · Bothell, WADirectorPaul Kang · La Jolla, CADirectorPaul Grayson · La Jolla, CAExec · DirectorAlyssa Lochbaum · La Jolla, CAExecPaul Kang · La Jolla, CADirectorPaul Grayson · La Jolla, CAExec · DirectorJerel Davis · Cleveland, OHDirectorCory Freedland · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗